Lead ANU researcher Aude Fahrer said an ongoing clinical trial of the Complete Freund Adjuvant treatment had shown promising results and could significantly improve outcomes for patients battling the disease.
If this works well, it will be a new treatment option with far fewer side effects, which will be available for cancer patients,” Associate Professor Fahrer said.
Associate Professor Fahrer said the new approach was less time-consuming and physically taxing than other cancer treatments such as chemotherapy.
“It involves injecting a slow-release solution of dead mycobacteria directly into the cancer,” Associate Professor Fahrer said.
While trials have only been conducted on late-stage human cancer patients so far, Associate Professor Fahrer said the new treatment was able to completely eliminate some earlier stage tumours in animal studies.
USA
UK
France
Germany
Russia
India
Canada